27P MiR-939-5p exhibits tumour suppressor activity and immune surveillance manipulation in triple-negative breast cancer

نویسندگان

چکیده

MiRNAs have been thoroughly studied for their vast roles in oncology, however, recent immune-related miRNAs recognized as prospective modulators the tumor immune surveillance process. The high immunogenicity of TNBC along with its stubbornness towards effective targeted therapy shifted therapeutic interests immunotherapy. Accordingly, a promising approach would be targeting suppressive microenvironment (TME). Such an could manifested dual manner through blocking prominent checkpoint proteins and regulating Natural Killer (NK) cells thus modifying TME. MiR-939-5p is scarcely explored miRNA especially TNBC. Therefore, our aim to identify expression profile miR-939-5p BC tissues role it plays suppression well immunomodulatory on NKG2D ligands Breast biopsies were collected from 40 patients. MDA-MB-231 cultured transfected different oligonucleotides. Total RNA was extracted quantified by qRT-PCR. Cellular viability, colony forming ability migration measured using MTT, scratch assays, respectively. down-regulated compared normal other subtypes. Functionally, forced ensued decline cellular capacity highlighting Immunomodulation wise, overexpression resulted down-regulation protein PD-L1 upregulation shedded MICA/B cells. Lastly, drastic repression inhibitory cytokines, TNF-? IL-10 detected upon upregulation. present study categorized suppressing under expressed patients cell lines. Furthermore, institutes first major stride unraveling advancing NK cytotoxicity trimming TME favor eradication, proposing novel module

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer

Emerging evidence has shown that adding poly(ADP-ribose) polymerase (PARP) inhibitors to chemotherapy regimens is superior to the control regimens alone in BRCA1-mutated triple-negative breast cancer (TNBC) patients, but their underlying mechanisms have not been fully elucidated. In this study, using miRNA microarray analysis of two BRCA1-mutated TNBC cell lines, we found that miR-664b-5p expre...

متن کامل

Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity

Conventional wisdom holds that only one of the two strands in a micro ribonucleic acid (miRNA) precursor duplex is selected as the active miRNA guide strand. The complementary miRNA passenger strand, however, is thought to be inactive. High levels of the oncogenic miRNA (oncomiR) guide strand called miR-17-5p is overexpressed in triple negative breast cancer (TNBC) and can inhibit ribosomal tra...

متن کامل

A Biomimetic Collagen Derived Peptide Exhibits Anti-Angiogenic Activity in Triple Negative Breast Cancer

We investigated the application of a mimetic 20 amino acid peptide derived from type IV collagen for treatment of breast cancer. We showed that the peptide induced a decrease of proliferation, adhesion, and migration of endothelial and tumor cells in vitro. We also observed an inhibition of triple negative MDA-MB-231 xenograft growth by 75% relative to control when administered intraperitoneall...

متن کامل

Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis

Background: Previous data have shown the tumorigenicity roles of HDAC8 in breast cancer. More recently, the oncogenic effects of this molecule have been revealed in TNBC. The present study aimed to determine the diagnostic value of HDAC8 for the differentiation of TNBC from nTNBC tumors. Methods: A total of 50 cancerous and normal adjacent tumor specimens were obtained, and the clinical and pat...

متن کامل

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer

The role of immune system in treating cancer is being increasingly seen as important [1]. Cancer cells have oncogenic mutations and express neo-antigens that make them distinct from normal cells thus prone to immune recognition. However, cells of innate and adaptive immune system which recognize and destroy these cells are held in check by various molecular pathways called “immune checkpoints” ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of Oncology

سال: 2021

ISSN: ['0923-7534', '1569-8041']

DOI: https://doi.org/10.1016/j.annonc.2021.01.041